EUS has a high efficacy in the detection of tumors smaller than 2 cm, for local T and N staging, and prediction of vascular invasion.
EUS has a higher resolution than transabdominal ultrasound, due to the small distance between the endoscope and pancreas through the wall of the duodenum.
↑Tawada K, Yamaguchi T, Kobayashi A, Ishihara T, Sudo K, Nakamura K, Hara T, Denda T, Matsuyama M, Yokosuka O (2009). "Changes in tumor vascularity depicted by contrast-enhanced ultrasonography as a predictor of chemotherapeutic effect in patients with unresectable pancreatic cancer". Pancreas. 38 (1): 30–5. PMID19117085.
↑Tamburrino D, Riviere D, Yaghoobi M, Davidson BR, Gurusamy KS (2016). "Diagnostic accuracy of different imaging modalities following computed tomography (CT) scanning for assessing the resectability with curative intent in pancreatic and periampullary cancer". Cochrane Database Syst Rev. 9: CD011515. doi:10.1002/14651858.CD011515.pub2. PMID27631326.
↑Yoon WJ, Daglilar ES, Fernández-del Castillo C, Mino-Kenudson M, Pitman MB, Brugge WR (2014). "Peritoneal seeding in intraductal papillary mucinous neoplasm of the pancreas patients who underwent endoscopic ultrasound-guided fine-needle aspiration: the PIPE Study". Endoscopy. 46 (5): 382–7. doi:10.1055/s-0034-1364937. PMID24619804.
↑Horton KM, Fishman EK (2002). "Multidetector CT angiography of pancreatic carcinoma: part I, evaluation of arterial involvement". AJR Am J Roentgenol. 178 (4): 827–31. doi:10.2214/ajr.178.4.1780827. PMID11906856.